Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model

doi:10.3748/wjg.v22.i21.5042

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13395)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

549

WORD

288

HTML

5395

Figures (1-4)

242

Tables (1-2)

192

Sum=6666

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1135

Download

5594

Sum=6729

Jun 7, 2016 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jun 7, 2016; 22(21): 5042-5049
Published online Jun 7, 2016. doi: 10.3748/wjg.v22.i21.5042

Full Size Figure Download Figure

Figure 2 The mean tumor growth ratio (V₂/V₁) by magnetic resonance imaging from each group. The mean tumor growth ratio (V₂/V₁) by MRI showed significant differences between group A (TACE + GRGDSP loaded nanoparticles), group B (control group 1, TACE + GRGDSP) and group C (control group 2, TACE alone) (P < 0.01). TACE: Transarterial chemoembolization. ¹Compared with group B (control group 1, TACE + GRGDSP); ²Compared with group C (control group 2, TACE alone).

Citation: Qian J, Oppermann E, Tran A, Imlau U, Qian K, Vogl TJ. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World J Gastroenterol 2016; 22(21): 5042-5049
URL: https://www.wjgnet.com/1007-9327/full/v22/i21/5042.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i21.5042